Copyright © Inderes 2011 - present. All rights reserved.
Log ind for at modtage meddelelser.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

C-Rad

39,3SEK +0,38%
Vær den første som følger denne virksomhed
c-rad.com/investors

C-Rad is active in medical technology. The company conducts the development, manufacturing, and sales of products and solutions in advanced radiation therapy. The business is mainly aimed at clinics that offer radiation treatment, where the company in addition to its core business offers associated installation services and support. The customers are located on a global level and the head office is located in Uppsala.

Omsætning
301,3 mio.
EBIT %
7,24 %
P/E
178,64
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
CRAD B
Daglig lav / høj pris
39,2 / 39,65 SEK
Markedsværdi
1,29 mia. SEK
Aktieomsætning
522,87 t SEK
Volumen
13 t

Finanskalender

Årsrapport
08.02.2024
Delårsrapport
14.05.2024
Generalforsamling
15.05.2024
Delårsrapport
18.07.2024
Delårsrapport
23.10.2024

Major Owners
Source: Millistream Market Data AB

OwnerCapitalVotes
Svea Ekonomi AB11,9 %11,9 %
Lars Kling7,9 %10,4 %
Premium
Not activated

This content is for our Premium customers only.

Sign inLearn more
ViserAlle indholdstyper
Pressemeddelelse
28.11.2023

C-RAD expands its presence in South Korea, soon supplying multiple centers with SGRT systems

C-Rad

Pressemeddelelse
01.11.2023

C-RAD celebrates success in the UK - SGRT tender won at Northern Centers for Cancer Care

C-Rad

Selskabsmeddelelse
27.10.2023

All-time high revenue and stable profitability

C-Rad

Pressemeddelelse
26.10.2023

Agreement at a value of 8 MSEK signed between C-RAD and new customer in Germany

C-Rad

Pressemeddelelse
24.10.2023

Reminder: C-RAD Web Presentation Interim Report Q3 2023

C-Rad

Pressemeddelelse
17.10.2023

C-RAD Web Presentation Interim Report Q3 2023

C-Rad

Selskabsmeddelelse
29.09.2023

C-RAD receives largest Proton Therapy order to date, counting to 10 complete end-to-end SGRT systems in Spain with an order value of 32 MSEK

C-Rad

Selskabsmeddelelse
29.09.2023

Agreement at a value of 16 MSEK signed between C-RAD and customer in North Rhine-Westphalia, Germany

C-Rad

Pressemeddelelse
28.09.2023

Atrium Health Levine Cancer to Help Patients Fight Cancer with New Equipment for Proton & Advanced Radiation Center

C-Rad

Selskabsmeddelelse
15.09.2023

Partnership agreement at a value of 10 MSEK signed between C-RAD and Katholisches Klinikum Bochum

C-Rad

Selskabsmeddelelse
28.08.2023

Repurchase of C-RAD B-shares in week 34, 2023

C-Rad

Selskabsmeddelelse
21.08.2023

Repurchase of C-RAD B-shares in week 33, 2023

C-Rad

Pressemeddelelse
14.08.2023

Breast cancer treatment option with surface guidance now available for clinical use in U.S.

C-Rad

Pressemeddelelse
31.07.2023

Former employee appeals verdict from the Patent and Market court of appeal

C-Rad

Selskabsmeddelelse
20.07.2023

Strong revenue growth and improved profitability

C-Rad

Selskabsmeddelelse
19.07.2023

C-RAD AB has decided to repurchase own shares in connection to C-RAD’s long term performance plan

C-Rad

Pressemeddelelse
18.07.2023

C-RAD to demonstrate enhancements in surface guided solutions for advanced radiotherapy treatments at AAPM

C-Rad

Pressemeddelelse
17.07.2023

Reminder: C-RAD Web Presentation Interim Report Q2 2023

C-Rad

Pressemeddelelse
11.07.2023

C-RAD Web Presentation Interim Report Q2 2023

C-Rad

Selskabsmeddelelse
01.07.2023

C-Rad will appeal the Patent and Market appeal court’s ruling about compensation to a former employee to the Supreme Court.

C-Rad

Forbinder investorer og virksomheder

Vores sociale mål er at demokratisere information på de finansielle markeder, så alle har lige muligheder for at investere og spare op til deres egen fremtid.

Tag kontakt
  • mie@hcandersencapital.dk
  • +45 28 74 66 40
  • Bredgade 23B, 2. sal
    1260 København K
  • Om os
  • Servicevilkår
  • Privatlivspolitik
  • Ansvarsfraskrivelse for research
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.